Heard the concall, felt good about it.
Can we estimate topline for FY 2024?
-Normally taking 30% growth on existing products takes the topline to 65 crores.
-Conservatively we can estimate 5Cr. from USA and other new markets.
-5 crores can come from new products.
On 70 crores revenue from first two items, 20 Crore PAT can be expected. Let us presume that there shall be no profit on new products.
Thus, presently the company is available at 410 Cr. Mcap, merely 20 times forward earning. Looks attractive.
[Disclosure- Invested]
| Subscribe To Our Free Newsletter |
